#2203 DeepBrain / Nvidia Canvas / IBM sells Watson / Sanofi and Exscientia / Meta
Episode description
DeepBrain AI's industry-first approach to "humanizing" AI assistants provides users with a familiar, insightful, and accessible experience.
https://gadget.co.za/ces-2022-deepbrain-humanises-ai-avatars/
It's amazing what we can do with AI these days.
https://www.pcgamer.com/nvidias-upgraded-ai-art-tool-turned-my-obscure-squiggles-into-a-masterpiece/
IBM has revived its sale process for IBM Watson Health with hopes of raising more than $1 billion, people familiar with the situation tell Axios.
French drugmaker Sanofi SA (SASY.PA) will partner with British AI company Exscientia Plc (EXAI.O) to develop up to 15 drug candidates in oncology and immunology, under an agreement worth up to $5 $.2 billion in milestone payments, the two companies said on Friday.
People use AI for a variety of speech recognition and language understanding tasks, from activating smart speakers to building tools for people with hearing or speech disabilities.
https://ai.facebook.com/blog/ai-that-understands-speech-by-looking-as-well-as-hearing